In this webinar, Dr. Mian will explore the impact of COVID-19 on ocular disease and Michael Titus will discuss Eversight's ongoing work to provide safe donor eye tissue. Come prepared with questions for this interactive webinar.
Michael Titus, CEBT, joined Eversight in 2017. He is the former Chief Clinical Officer of Saving Sight, an eye bank in Kansas City, Missouri, where he successfully crafted the strategic direction of its clinical program, oversaw lab renovations and improved tissue quality and surgeon satisfaction. Prior to his time at Saving Sight, Titus excelled in various roles with Eversight from 2008 to 2013, including managing the laboratory in Michigan and playing an instrumental role in developing the Eversight DMEK program. He is a Certified Eye Bank Technician (CEBT) and currently serves on the Eye Bank Association of America (EBAA) Research Committee and Accreditation Board.
Shahzad I. Mian, MD, is a professor of ophthalmology and visual sciences at the University of Michigan Medical School (Kellogg Eye Center, Michigan Medicine). He also serves the Department as Associate Chair for Education. He earned his medical degree in 1996 from the Emory University School of Medicine and then completed a residency at the Wills Eye Hospital of Thomas Jefferson University in Philadelphia. From 2000 to 2002, Dr. Mian was a fellow in cornea and refractive surgery at Mass. Eye and Ear, Harvard Medical School. He joined the Michigan Medicine faculty in 2002 as a clinical lecturer in ophthalmology and visual sciences and was promoted to associate professor in 2010.